Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass; Edward P. Lawrence Center for Quality and Safety, Massachusetts General Hospital, Boston, Mass.
Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Medical Practice Evaluation Center, Department of Medicine, Massachusetts General Hospital, Boston, Mass.
J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):1019-1027.e2. doi: 10.1016/j.jaip.2017.08.006. Epub 2017 Sep 22.
Unverified penicillin allergy leads to adverse downstream clinical and economic sequelae. Penicillin allergy evaluation can be used to identify true, IgE-mediated allergy.
To estimate the cost of penicillin allergy evaluation using time-driven activity-based costing (TDABC).
We implemented TDABC throughout the care pathway for 30 outpatients presenting for penicillin allergy evaluation. The base-case evaluation included penicillin skin testing and a 1-step amoxicillin drug challenge, performed by an allergist. We varied assumptions about the provider type, clinical setting, procedure type, and personnel timing.
The base-case penicillin allergy evaluation costs $220 in 2016 US dollars: $98 for personnel, $119 for consumables, and $3 for space. In sensitivity analyses, lower cost estimates were achieved when only a drug challenge was performed (ie, no skin test, $84) and a nurse practitioner provider was used ($170). Adjusting for the probability of anaphylaxis did not result in a changed estimate ($220); although other analyses led to modest changes in the TDABC estimate ($214-$246), higher estimates were identified with changing to a low-demand practice setting ($268), a 50% increase in personnel times ($269), and including clinician documentation time ($288). In a least/most costly scenario analyses, the lowest TDABC estimate was $40 and the highest was $537.
Using TDABC, penicillin allergy evaluation costs $220; even with varied assumptions adjusting for operational challenges, clinical setting, and expanded testing, penicillin allergy evaluation still costs only about $540. This modest investment may be offset for patients treated with costly alternative antibiotics that also may result in adverse consequences.
未经证实的青霉素过敏会导致不良的下游临床和经济后果。青霉素过敏评估可用于识别真正的 IgE 介导的过敏。
使用时间驱动作业成本法(TDABC)估算青霉素过敏评估的成本。
我们在 30 名因青霉素过敏评估而就诊的门诊患者的整个护理路径中实施了 TDABC。基础评估包括由过敏专家进行青霉素皮试和一步阿莫西林药物挑战。我们对提供者类型、临床环境、程序类型和人员时间进行了各种假设。
在 2016 年的美元中,基础案例的青霉素过敏评估成本为 220 美元:人员费用为 98 美元,耗材费用为 119 美元,空间费用为 3 美元。在敏感性分析中,当仅进行药物挑战(即无皮试)且使用执业护士提供者时,成本估算较低(即 84 美元)。调整过敏反应的可能性并未导致估计值发生变化(即 220 美元);尽管其他分析导致 TDABC 估计值略有变化(214-246 美元),但当改变到低需求实践环境(268 美元)、人员时间增加 50%(269 美元)以及包括临床医生记录时间(288 美元)时,估计值会有所增加。在最少/最多昂贵的情况下分析中,TDABC 的最低估计值为 40 美元,最高值为 537 美元。
使用 TDABC,青霉素过敏评估的成本为 220 美元;即使考虑到操作挑战、临床环境和扩展测试的各种假设,青霉素过敏评估的成本仍仅为 540 美元左右。这种适度的投资可能会被患者因使用昂贵的替代抗生素而得到弥补,这些抗生素也可能会导致不良后果。